September 27, 2023 | 12:30 CEST



This course is aimed at residents in their final year of training in radiology and recently board-certified radiologists interested in Hybrid Imaging. It strictly adheres to Level II of the European Training Curriculum and is designed to increase the integrated usage of the diagnostic power of hybrid equipment in oncological and inflammatory diagnosis, follow-up and response assessment.

The course includes six topics consisting of 40 minutes of theory and case presentations followed by a live Q&A section after each session for interaction with the faculty members.



  • to understand the indications, limitations and comparative merits of each part of hybrid
    imaging in common diseases
  •  to learn about the evaluation of hybrid imaging
  • to get a basic knowledge of tracers and radiopharmaceuticals for hybrid imaging
  •  to learn about imaging techniques, protocols and artefacts in hybrid imaging


Wednesday, September 27, 2023


The beauty of Hybrid Imaging – the tech basics
T. Beyer, Vienna/AT

  • To understand the definition of hybrid imaging
  • To appreciate the breadth of HI devices in clinical routine
  • To comprehend the benefits (and key challenges) of hybrid imaging technologies

FDG PET/CT in oncology: where is it in the guidelines
C. Cyran, Munich/DE

  • To learn about the principles of FDG PET/CT
  • To get acquainted with the key applications of FDG PET/CT in oncologic therapy guidance
  • To study the tumour entities where FDG PET/CT is in the guidelines for therapy management and why

Hybrid imaging in infection and inflammation
J.L. Vercher-Conejero, Barcelona/ES

  • To understand the role of hybrid imaging in infection and inflammation.
  • To learn about the different radiopharmaceuticals that may be used in infection and inflammation processes.
14:30-15:00 Q&A
15:00-15:30 Break

PSMA PET/CT for guiding therapy in prostate cancer
C. Cyran, Munich/DE

  • To learn about the principles of PSMA PET/CT
  • To study the key applications of PSMA PET/CT in prostate cancer
  • To get acquainted with the theranostic concept of PSMA ligands

FAPI: still the next big thing
L. Unterrainer, Munich/DE

  • To define the current use and future perspectives of FAPI PET in oncological imaging/comparison to FDG PET/CT
  • To define the current use and future perspectives of FAPI PET in non-oncological diseases/comparison to FDG PET/CT
  • Outlook: FAP-targeted therapy

Total body PET/CT: the revolution in sight
T. Beyer, Vienna/AT

  • To define “total body” (vs “whole body”)
  • To briefly review the origins of TB-PET(/CT)
  • To sketch out current applications highlighting the versatility/flexibility of TB-PET
  • To dream about future applications
17:30-18:00 Q&A

On-Demand availability

You will find the on-demand recording of this course in the "My Courses" section of your ESR Connect account. The recording will be available until December 31, 2023.


How to collect CME credits

A CME certificate will be issued automatically if the following criteria are met:

  • You need to attend the course online via live stream in full length.
  • You have to complete the electronic evaluation questionnaire. To do so, please click the "Course Evaluation" button displayed on the right column of the course page or go to the section "My Evaluation" of your ESR Connect account.

Evaluation is open from April 26, 18:30 CET until May 3, 23:59 CET and CME certificates can be downloaded in your ESR Connect user area under 'My Certificates'.